{
    "clinical_study": {
        "@rank": "146532", 
        "brief_summary": {
            "textblock": "The purpose of this study is to look at the safety and effectiveness of dextrin sulfate in\n      AIDS patients who have failed conventional anti-HIV treatment."
        }, 
        "brief_title": "Treatment of Advanced AIDS Patients With Dextrin Sulfate", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients have intraperitoneal (IP) catheter placement done at study entry. Infusion with the\n      carrier vehicle (icodextrin 4%) begins 2 weeks later, and 2 days after that, treatment with\n      dextrin sulphate (DS) commences. DS is given three times per week. A nurse delivers initial\n      treatments and the patient and caregiver will be trained to give subsequent treatments until\n      DS has been given a total of 8 weeks. Patient evaluations are done regularly during\n      treatment and observation continues for 24 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients may be eligible for this trial if they:\n\n          -  Are HIV-positive.\n\n          -  Have been diagnosed with AIDS and are under treatment to prevent opportunistic\n             (AIDS-related) infection.\n\n          -  Have had a CD4 cell count greater than 50 microL for at least the past 3 months.\n\n          -  Have had a viral load of at least 50,000 copies/ml for at least the past 3 months.\n\n          -  Have used up all other treatment options.\n\n          -  Are able to understand and give written consent.\n\n        Exclusion Criteria\n\n        Patients may not be eligible for this trial if they:\n\n          -  Have been in any other study in the 6 weeks before beginning this study.\n\n          -  Have an active, opportunistic infection or other infection.\n\n          -  Have any other long-term medical condition or nervous disorder that might make it\n             difficult for them to finish the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "March 16, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004987", 
            "org_study_id": "309A"
        }, 
        "intervention": {
            "intervention_name": "Dextrin 2-sulfate", 
            "intervention_type": "Drug"
        }, 
        "keyword": [
            "Anti-HIV Agents", 
            "Viral Load", 
            "dextrin 2-sulfate", 
            "Infusions, Parenteral"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Miami", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "33133"
                }, 
                "name": "Steinhart Medical Associates"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Intraperitoneal Dextrin Sulfate in Patients With Advanced HIV Disease: A Phase I Trial", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004987"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Steinhart Medical Associates", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 1999", 
        "study_design": "Endpoint Classification: Safety Study, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2001"
    }, 
    "geocoordinates": {
        "Steinhart Medical Associates": "25.789 -80.226"
    }
}